These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 12796612
1. Response to a phase II study of concomitant-to-sequential use of etoposide and radiation therapy in newly diagnosed malignant gliomas. Beauchesne P, Soler C, Boniol M, Schmitt T. Am J Clin Oncol; 2003 Jun; 26(3):e22-7. PubMed ID: 12796612 [Abstract] [Full Text] [Related]
11. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A, O'Neill A, Drappatz J, Chen-Plotkin AS, Ramakrishna N, Weiss SE, Levy B, Bradshaw J, Kracher J, Laforme A, Black PM, Folkman J, Kieran M, Wen PY. Neuro Oncol; 2007 Jul 01; 9(3):354-63. PubMed ID: 17452651 [Abstract] [Full Text] [Related]
13. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma. Kakolyris S, Agelidou A, Androulakis N, Tsaroucha E, Kouroussis Ch, Agelidou M, Karvounis N, Veslemes M, Christophylakis Ch, Argyraki A, Geroyianni A, Georgoulias V. Lung Cancer; 2006 Jul 01; 53(1):59-65. PubMed ID: 16716447 [Abstract] [Full Text] [Related]
14. Salvage therapy with oral etoposide in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Gedlicka C, Kornfehl J, Turhani D, Burian M, Formanek M. Cancer Invest; 2006 Jul 01; 24(3):242-5. PubMed ID: 16809151 [Abstract] [Full Text] [Related]
19. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study. Korones DN, Fisher PG, Kretschmar C, Zhou T, Chen Z, Kepner J, Freeman C. Pediatr Blood Cancer; 2008 Feb 01; 50(2):227-30. PubMed ID: 17278121 [Abstract] [Full Text] [Related]
20. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy. Jennings MT, Cmelak A, Johnson MD, Moots PL, Pais R, Shyr Y. Pediatr Blood Cancer; 2004 Jul 01; 43(1):46-54. PubMed ID: 15170889 [Abstract] [Full Text] [Related] Page: [Next] [New Search]